Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-26 @ 5:18 PM
Ignite Modification Date:
2025-12-26 @ 5:18 PM
NCT ID:
NCT03330106
Group ID:
EG002
Title:
Part B: Pevonedistat 25 mg/m^2 + Docetaxel
Description:
Pevonedistat 25 mg/m\^2 in combination with docetaxel 75 mg/m\^2, infusion, IV, once on Day 1 followed by pevonedistat 25 mg/m\^2 IV, once on Days 3 and 5 in each 21-day treatment cycle for up to Cycle 45 or symptomatic deterioration or progressive disease (PD), or until treatment is discontinued for another reason. Pevonedistat was administered after the docetaxel chemotherapy. Participants who completed Part A and provided consent for Part B continued treatment in Part B.
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
13
Serious Number At Risk:
23
Other Number Affected:
23
Other Number At Risk:
23
Study:
NCT03330106
Results Section:
NCT03330106
Adverse Events Module:
NCT03330106